Neutralizing antibody levels against SARS-CoV-2 variants of concern Delta and Omicron in vaccine breakthrough-infected blood donors.

Massimo Franchini Daniele FocosiCarlo MengoliElena PercivalleJosè Camilla SammartinoAlessandro FerrariMatteo ZaniClaudia GlinganiFausto Baldanti

Published in: Transfusion (2022)

SARS-CoV-2 breakthrough infection in vaccinated in donors boosts nAb titers against VOCs Delta and Omicron, but such titers decay shortly after infection. Therefore, CCP must be collected early after vaccine breakthrough infection.

Keyphrases

sars cov
respiratory syndrome coronavirus
copy number
gene expression
dna methylation
zika virus
coronavirus disease